<DOC>
	<DOCNO>NCT00162188</DOCNO>
	<brief_summary>This study conduct assess safety tolerability oral liquid solution Sustiva antiretroviral therapy-naive therapy-experienced HIV-1 infected child age 3-16 fail intolerant current antiretroviral regimen unable swallow Sustiva capsule .</brief_summary>
	<brief_title>An Expanded Access Study Oral Liquid Efavirenz Treatment Children With HIV Infection : Canada</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>Children 316 year age Antiretroviral naive experience Failing intolerant current antiretroviral ( ARV ) regimen Limited available viable therapeutic option Inability take capsules/tablets Weighs le 10 kg Failure concomitant use nonnucleoside reverse transcriptase inhibitor ( NNRTIs ) An active AIDSdefining opportunistic infection disease More two episode moderate severe diarrhea vomit last four day within past three month</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>